Clinical Trials Directory

Trials / Completed

CompletedNCT01303627

Safety of Remifentanil Infusion

The Effects of Maintenance a Remifentanil Infusion on the Hemodynamic Variables and Recovery Quality

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
42 (actual)
Sponsor
Diskapi Teaching and Research Hospital · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The effect of maintenance remifentanil infusion with target controlled infusion during laryngeal mask airway removal on hemodynamic parameters and emergence quality is going to be investigated.

Detailed description

In all patients (control group and remifentanil group induction of anesthesia will be achieved with desflurane and remifentanil.Anesthesia will be maintained with remifentanil (1-4 ng/mL) by TCI target controlled infusion, and desflurane . Throughout the surgery hemodynamic parameters are going to be recorded. As soon as the surgery has been finished, in control group remifentanil infusion and desflurane inhalation is going to be stopped.In remifentanil group,desflurane inhalation is going to be stopped and remifentanil infusion will be maintained until the removal of LMA. During the emergence period the time of eye opening, hemodynamic parameters and emergence quality (score 1-2)are going to be recorded.

Conditions

Interventions

TypeNameDescription
DRUGremifentanil1-4 ng/mL i.v. infusion during the surgery, maintenance dosage till LMA removal is 1.5 ng/mL.

Timeline

Start date
2011-02-01
Primary completion
2011-03-01
Completion
2011-04-01
First posted
2011-02-25
Last updated
2012-06-25
Results posted
2012-06-18

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT01303627. Inclusion in this directory is not an endorsement.